How a Mohali Pharmaceutical Company Cut Compliance Costs by 40% with SAP B1

Company Background

Medisure Pharma Pvt. Ltd. is a pharmaceutical formulation manufacturer headquartered in Phase VIII-B, Industrial Area, Mohali, Punjab. Founded in 2011, the company manufactures over 140 formulations across tablets, capsules, oral liquids, and topical preparations. With an annual turnover of approximately INR 72 crore, Medisure supplies to government tender programmes, private hospital chains, and exports to East African markets through three registered importers.

The company operates a single manufacturing facility spread across 22,000 sq. ft. with WHO-GMP certification and employs 165 people, including 12 qualified pharmacists across quality assurance, quality control, and regulatory affairs. Their product portfolio includes analgesics, antibiotics, antidiabetics, and dermatological preparations — many of which fall under Schedule H and Schedule H1 of the Drugs and Cosmetics Rules.

Prior to engaging with Indivar Software Solutions, Medisure was running Tally ERP 9 for financials, a locally developed Visual Basic application for batch records, and an assortment of Excel spreadsheets for regulatory tracking, stability studies, and vendor qualification records. The regulatory affairs team maintained paper-based registers for Schedule H/H1 sales and drug licence tracking.

The Challenge

Medisure's compliance challenges had been building for years, but the tipping point arrived in mid-2025 when two events occurred in quick succession:

• A CDSCO inspection resulted in three observations — two related to batch traceability gaps (the team could not produce complete backward traceability for a randomly selected finished goods batch within the allotted time) and one related to incomplete Schedule H1 sales registers. The observations were not critical enough to warrant licence suspension, but the message was unmistakable: fix these issues before the next inspection.
• A key hospital chain customer demanded full batch genealogy documentation as a precondition for renewing their annual supply contract worth INR 4.2 crore. The purchasing director was explicit — if Medisure could not provide end-to-end traceability within 24 hours of a query, the contract would move to a competitor.

Beyond these triggering events, the underlying problems were systemic:

• Compliance was a manual, labour-intensive exercise — the regulatory affairs team of four people spent an estimated 55-60% of their time on documentation, register maintenance, and audit preparation rather than on actual regulatory strategy and product registration work
• Batch traceability required cross-referencing four separate systems — the VB application for production batch records, Tally for purchase invoices (to identify raw material suppliers), a handwritten stores register for material issue records, and Excel sheets for QC test results. A complete trace took 4-6 hours
• Expiry management was reactive — the company had written off INR 18 lakh worth of expired raw materials and finished goods in the previous financial year. FEFO (First Expiry, First Out) was a stated policy but not enforced by any system
• Drug licence tracking for 28 C&F agents and 420+ stockists was maintained in Excel — three licences had expired without detection, resulting in dispatches to unlicensed entities that were caught only during an internal audit
• Annual compliance costs were estimated at INR 38 lakh — including salaries of staff dedicated primarily to compliance paperwork, CA and consultant fees for audit preparation, penalty payments for minor violations, and the cost of expired stock write-offs

"We were spending more on managing compliance than on product development. Our pharmacists — highly qualified professionals — were filling out registers and cross-referencing spreadsheets instead of focusing on formulation work and regulatory filings. That is not just a cost problem, it is a talent problem."

— Dr. Ramandeep Kaur, Director, Medisure Pharma

The Solution

After a two-week assessment, Indivar Software Solutions proposed a comprehensive implementation of SAP Business One with our Pharma Addon, designed specifically for Indian pharmaceutical manufacturers operating under CDSCO regulations.

Phase 1: Core ERP Foundation (Weeks 1-8)

SAP Business One was implemented across purchasing, inventory, sales, production, and financials. The critical foundation decisions included:

• Mandatory batch management activated for every inventory item — raw materials, packing materials, intermediates, and finished goods. Each batch record carries manufacturing date, expiry date, supplier batch reference, internal batch number, quality status, and a complete set of configurable quality attributes
• FEFO picking configured as the default and only allocation strategy for all dispatch operations — the system physically prevents dispatching a batch with a later expiry when an earlier-expiry batch of the same item is available
• Warehouse segmented into seven logical zones: quarantine (incoming), approved raw materials, approved packing materials, WIP staging, finished goods quarantine, finished goods approved, and rejected/expired. Movement between zones requires QC clearance
• Automatic financial postings configured so that every inventory movement, production receipt, and dispatch generates the corresponding journal entries without manual intervention

Phase 2: Pharma Addon Deployment (Weeks 9-14)

The Indivar Pharma Addon for SAP B1 extended the base system with pharmaceutical-specific compliance functionality:

• Drug Licence Management: Every customer, C&F agent, and stockist record now includes their drug licence number, licence type (wholesale, retail, restricted), validity date, and the list of drug categories they are licensed to purchase. The system blocks delivery note creation for any entity whose licence has expired or does not cover the product category being shipped. Automatic email alerts are dispatched at 60, 30, and 15 days before licence expiry — both to the internal team and to the customer
• Schedule H/H1 Digital Register: Every sale of a Schedule H or H1 drug automatically populates the statutory register with buyer details (name, address, licence number), quantities, batch numbers, invoice reference, and date of sale. The register is printable in the format prescribed by the state drug controller and is always current
• Batch Genealogy Engine: A single-click trace report provides complete forward and backward traceability. Starting from any finished goods batch, the system traces backward through production batch records to every raw material batch consumed (with supplier details, CoA references, and QC results), and forward to every customer and location where the batch was dispatched (with invoice numbers and quantities). The complete trace executes in under 90 seconds
• Stability Study Tracking: Stability study protocols are defined per product with scheduled pull dates. The system generates automatic alerts for upcoming sample pulls and flags batches where stability data suggests a potential shelf-life concern
• Recall Simulation: A mock recall can be initiated by entering a batch number. The system instantly identifies every dispatch point, generates notification letters for affected parties, and calculates the quantity to be recalled — enabling the company to complete mock recall exercises within the timeframes expected by auditors

Phase 3: GST Compliance Integration (Weeks 15-18)

The EInvoice Addon and EWayBill Addon were deployed to automate GST compliance. E-invoices and e-Way Bills now generate automatically from SAP B1 transactions with zero manual portal interaction.

Results

The results were measured over the first eight months post go-live and validated through internal audits, external ISO audits, and a follow-up CDSCO inspection:

• Total compliance costs reduced by 40% — from INR 38 lakh annually to an estimated INR 22.8 lakh. The savings came from reduced manual effort (two regulatory affairs staff redeployed to product registration work), elimination of expired stock write-offs (INR 18 lakh saved), and zero penalties
• Batch traceability time reduced from 4-6 hours to under 90 seconds — the follow-up CDSCO inspection specifically tested this capability, and the inspector noted the system-generated trace report as exemplary
• Zero CDSCO observations on the follow-up inspection — compared to three observations on the previous visit. The inspector specifically commended the digital Schedule H1 register and the automated drug licence validation
• Expired stock write-offs eliminated — FEFO enforcement and automated near-expiry alerts (at 6-month, 3-month, and 1-month thresholds) ensured that stock approaching expiry was proactively distributed to high-turnover outlets or returned to the production plan for repackaging where permissible
• Drug licence compliance achieved 100% — zero dispatches to expired or unlicensed entities since go-live. The system blocked 11 attempted dispatches to entities with expired licences in the first four months alone
• Hospital chain contract worth INR 4.2 crore renewed — the purchasing director was shown a live batch trace demonstration during a vendor audit visit. The contract was renewed for three years
• Audit preparation time reduced from 3-4 weeks to 3 days — because compliance data is generated as a byproduct of daily operations, not as a separate exercise
• Regulatory affairs team productivity increased by approximately 55% — the four-person team now spends the majority of their time on new product registrations and regulatory strategy rather than register maintenance and audit preparation

"The transformation is night and day. When the CDSCO inspector asked for a batch trace, our QA manager pulled it up on screen in about a minute. The inspector spent more time reviewing the report than we spent generating it. That is exactly how compliance should work — the system does the heavy lifting."

— Dr. Ramandeep Kaur, Director

Key Learnings

• Compliance should be a byproduct, not a project. If your team has to "prepare" for an audit, your systems are not designed correctly. Every daily transaction in SAP B1 automatically builds the compliance record. When the auditor arrives, the data is already there — no compilation, no reconciliation, no last-minute scramble
• Drug licence validation must be system-enforced. No amount of training or process documentation can match the reliability of a system that physically blocks a dispatch to an unlicensed entity. Human-dependent checks will always have gaps; system-enforced controls do not
• FEFO enforcement pays for itself through expiry prevention. Medisure's INR 18 lakh annual write-off was eliminated entirely. For many pharma companies, the savings from expiry prevention alone exceed the cost of the ERP implementation within the first year
• Invest in clean data migration. Converting 140 product batch histories from the legacy VB application and paper records into SAP B1 required a dedicated team working for four weeks. The temptation to cut corners on data migration is strong, but incomplete historical data undermines the value of the genealogy engine
• Regulatory staff should be doing regulatory work, not clerical work. The redeployment of two pharmacists from register maintenance to product registration work has already resulted in four new product filings — each representing potential revenue that was previously forgone because the team simply did not have the bandwidth

Is Your Pharmaceutical Business Audit-Ready?

If your pharmaceutical company is spending more on compliance paperwork than on product development, or if a CDSCO inspection makes your team nervous, it is worth having a conversation about what systematic compliance looks like. At Indivar Software Solutions, we have implemented SAP Business One with our Pharma Addon at pharmaceutical manufacturers across Punjab, Himachal Pradesh, and Gujarat. Get in touch with us for a confidential assessment of your compliance readiness.